Key result
Nasal wash and bronchoalveolar lavage respiratory viral panels showed exact concordance in 45 of 58 (77.6%) immunocompromised adult patients when performed within 5 days of each other.
Why the study?
Does multiplex real-time PCR respiratory viral panel testing on nasal wash specimens provide the same results as bronchoalveolar lavage specimens in immunocompromised adult patients?
Observational (n=58)
Does multiplex real-time PCR respiratory viral panel testing on nasal wash specimens provide the same results as bronchoalveolar lavage specimens in immunocompromised adult patients?
Nasal wash and bronchoalveolar lavage respiratory viral panels show good correlation when performed within 5 days of each other in immunocompromised adults.
Nasal wash may substitute for BAL in respiratory viral testing for immunocompromised adults; leaves open need for larger prospective validation before routine use.
Purpose: To determine if the multiplex real-time polymerase chain reaction respiratory viral panel (RVP) provides the same results when performed on nasal wash versus bronchoalveolar lavage from the same patient within 5 days of each other. Methods: A retrospective chart review was performed on all adult immunocompromised patients who underwent bronchoalveolar lavage (BAL) with a respiratory viral panel (RVP) obtained from the BAL fluid from February 2011 to July 2012. All patients who also had a nasal wash RVP performed within 5 days of the BAL assay were included in this study. Results: There was exact concordance between BAL and NPW specimens in 45 of 58 patients: 26 cases in which both specimens were negative and 19 cases in which the exact same viruses were present in each specimen. In 8 cases, a virus was detected in BAL fluid that was not detected in NPW fluid; in 5 cases, a virus was found in NPW fluid but not BAL. Conclusions: There was good correlation between the two assays when performed within 5 days of each other from the 2 separate specimen sources. For optimal diagnostic detection, it may be useful to repeat the assay in both locations when clinically indicated.
No takes yet. Share an insight, caveat, or question.
A 2014 study conducted an observational in Immunocompromised (n=58). Nasal wash respiratory viral panel vs. Bronchoalveolar lavage respiratory viral panel was evaluated on Exact concordance between BAL and NPW specimens. Nasal wash and bronchoalveolar lavage respiratory viral panels showed exact concordance in 45 of 58 (77.6%) immunocompromised adult patients when performed within 5 days of each other.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: